Navigation Links
Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy
Date:3/26/2009

INDIANAPOLIS, March 26 /PRNewswire/ -- A coalition of Indiana's leaders in research, medicine, public health, education, labor and business joined today to launch Hoosiers Work for Health (www.hoosiersworkforhealth.org) to stress the importance of preserving medical innovation. Co-chairs, former Indianapolis Mayor Bart Peterson, and the President of the Pacers Sports & Entertainment Jim Morris, kicked off the effort at the Indiana Statehouse.

Hoosiers Work for Health will highlight the importance of biopharmaceutical research and innovation on Indiana's economy. The partnership includes local chambers of commerce, research centers, labor, businesses, patient advocacy organizations, provider groups and biopharmaceutical sector employees who work to provide a better quality of life to all Hoosiers. Hoosiers Work for Health will focus on providing information and educating Hoosiers about the sector and how it affects them.

Today's kickoff will initiate an aggressive, statewide education effort, focused on bringing Hoosiers together on the issues of healthcare access, provision and innovation. Our partners will hold informational meetings, health fairs and industry site visits to assure that all Hoosiers understand the impact of the life sciences sector in Indiana and how best to assure it continues to grow here at home.

"Hoosiers Work for Health was created to highlight its partners' dedication to innovation, research and development of new cures; their contributions to state and local philanthropic causes; and their far-reaching presence as an economic force," said co-chair, Jim Morris. "Our partners support policies that recognize the value of innovation and take steps to preserve and foster America's ability to innovate."

Hoosiers Work for Health is one of ten state chapters of We Work for Health, a national effort
'/>"/>

SOURCE Hoosiers Work for Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Prime Health Network and Its Patients Thrive in Tough Economic Times on the InstaMed Network
2. TeleHealth Services and Lakeland HealthCare Connect to Create Outstanding Patient Experience
3. The NIHR Biomedical Research Centre for Mental Health London has Joined the MetaMiner CNS Partnership Program
4. New Online Imaging Suite Boosts Healthcare Imaging Efficiency, Productivity, and Revenues
5. RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference
6. Healthcare Institutions Can Now Stay Confidently Up-to-Date With New Regulatory Compliance Calendar
7. Gundersen Lutheran Health System is Recognized for Safe Lifting Leadership
8. Amgen to Present at the Cowen and Company Annual Healthcare Conference
9. RoundTable Healthcare Partners Facilitates Product Acquisition for CorePharma
10. PDHI Launches Short Form of Its ConXus Profile Health Assessment
11. Novavax to Present at Cowen and Company 29th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... to $5.8 million and provides a good start to Q4.  The ... America and one in the Middle East ... record levels," said Peter Bruijns , President & CEO. "Total ... Q3 than they have been for any complete year since the ...
(Date:10/20/2014)... PLAINSBORO, N.J. (PRWEB) October 20, 2014 ... that the Sidney Kimmel Cancer Center at Thomas ... program. , Through the Strategic Alliance Partnership ... and OncLive will collaborate to raise awareness of ... cancer treatment, and other projects. Clinicians and other ...
(Date:10/19/2014)... OCTOBER 20-22, 2014: The 9th Annual ... take place at the Congress Center Basel, ... now available at http://www.abim.ch . ... from all over the globe will exchange ... products and developments on the world market. ...
Breaking Biology Technology:Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3
... PRXL ), a leading global biopharmaceutical services,organization, ... Goldberg, M.D.,to Chief Operating Officer (COO). Dr. Goldberg ... Perceptive Informatics at,PAREXEL. He will continue to oversee ... von Rickenbach, Chairman and Chief Executive Officer of ...
... Sagent Pharmaceuticals, Inc.,a privately-held specialty pharmaceutical company, today ... USP, and cefuroxime for,injection, USP, two broad spectrum ... Sagent,s ceftriaxone for,injection will be available to the ... single,dose vials, as well as 1g and 2g ...
... PALO ALTO, Calif., July 16 Jazz,Pharmaceuticals, Inc. ... has entered,into definitive agreements with selected investors to ... of (i) one share of the Company,s,common stock, ... (ii) a,warrant to purchase 0.45 of a share ...
Cached Biology Technology:PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer 2PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer 3PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer 4Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP 2Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP 3Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering 2Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering 3
(Date:10/15/2014)... As our ability to assess the pandemic risk from ... developments, we must not allow ourselves to become complacent ... an international consortium of scientists. , Influenza pandemics arise ... have yet to develop widespread immunity – spreads in ... in the past 100 years, the worst of which ...
(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... thieves, prostate cancer tumors scavenge and hoard copper that ... avarice may be a fatal weakness. , Researchers ... prostate cancer cells by delivering a trove of copper ... cells brimming with the mineral, leaving non-cancer cells healthy. ... commercially available for other uses, could soon be tested ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Prostate cancer's penchant for copper may be a fatal flaw 2
... have devised a means of identifying partial, distorted, scratched, ... seconds. Previous techniques have tried to identify a ... match them against a database of templates. The University ... each print and transform the topological pattern into a ...
... issue of G&D, Dr. Guillermo Oliver (St. ... evidence to resolve a century-old debate over the ... development of the lymphatic vasculature is integral to ... and maintaining tissue fluid levels) and disease (lymphedema ...
... Acid rain was one of the worlds worst pollution problems ... Britain, as well as Europe and North America. In ... been acidified, harming fish, stream insects and river birds such ... has been taken across Europe to clean up acid pollutants ...
Cached Biology News:New technology identifies warped fingerprints at warp speed 2Recovery from acid rain 'much slower than expected' 2
Low melting point. Ideally suited for in gel enzymatic reactions. Gelling temp. 24-28C Melting temp. 65C. EEO 0.12 Resolution 0.5-20 kb; Rnase/Dnase: none detected....
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
...
Biology Products: